Skip to main content
Poole in the News

TEC Program’s Locus Biosciences Develops Tool to Fight Bacterial Infections

Locus Biosciences has developed bacteriophage therapies to target pathogens and fight infections. Locus began as a Technology, Entrepreneurship & Commercialization (TEC) Program project in 2015 led by CEO Paul Garofolo, two Poole professors and a graduate student who eventually launched the startup that May.

The company spent a year developing in a lab on NC State’s centennial campus for a year prior to moving to a permanent location in Research Triangle Park.

Read more on Science Board.